Search for: "Pharmaceutical Generic Developers, Inc."
Results 161 - 180
of 1,119
Sorted by Relevance
|
Sort by Date
15 Jan 2014, 7:38 am
Pharmaceutical Works and Japanese company Astellas Pharma Inc; if you must know, the patent is for novel quinuclidine derivatives and pharmaceutical preparations. [read post]
10 May 2012, 9:00 am
Gorbec Pharmaceutical Services, Inc. [read post]
23 Aug 2011, 11:53 am
AMAG Pharmaceuticals is focused on the development of therapeutic iron to treat iron deficiency anemia. [read post]
17 May 2007, 9:09 am
Teva Pharmaceuticals USA Inc., No. 06-0282, 22 BNA Toxic Law Rptr. #20 (S.D. [read post]
30 May 2019, 5:09 am
” Informed, Inc. [read post]
24 Oct 2012, 3:51 pm
With respect to potential remedy, KV requests that the Commission issue a general exclusion order and a cease and desist order barring imports of HPC. [read post]
13 Feb 2014, 9:04 am
According to the complaint, the Cipla entities are engaged in the generic-pharmaceutical business. [read post]
11 Feb 2019, 12:15 pm
Teva Pharmaceutical Industries, Ltd. and Teva Pharmaceuticals USA, Inc. [read post]
23 May 2014, 6:08 pm
Watson Pharma., Inc., No. 2013-1409 (Fed. [read post]
12 Jul 2010, 9:40 am
Mylan Pharmaceuticals Inc., C.A. 09-184-... [read post]
19 Apr 2021, 9:37 am
Here are some of the developments in antitrust news this past week that we found interesting and are following. 4th Circuit revives antitrust claims against Actelion over Tracleer pricing. [read post]
7 Apr 2016, 6:25 am
Concordia Pharmaceuticals, Inc. v. [read post]
15 Sep 2011, 4:06 am
Co., Inc., 480 Pa. 547, 559, 391 A.2d 1020, 1027 (1978). [read post]
10 May 2012, 9:00 am
Gorbec Pharmaceutical Services, Inc. [read post]
22 Jan 2015, 3:46 pm
” In Teva Pharmaceuticals USA, Inc. v. [read post]
6 Nov 2020, 7:16 am
” On the facts here: Mylan Pharmaceuticals Inc. [read post]
28 May 2014, 10:31 am
The gel had been developed from a pharmaceutical formula by Besins Healthcare, S.A. [read post]
8 Nov 2016, 11:53 pm
Among the generic drug companies experiencing this share price decline were Allergan, Teva Pharmaceuticals, and Endo Pharmaceuticals. [read post]
2 Oct 2013, 6:00 am
· Mnemosyne Pharmaceuticals Inc., of Providence, received a $5,166,000 early stage investment from existing investors Atlas Venture Advisors Inc. and Clol Biotechnology Industries, Ltd. [read post]
2 Oct 2013, 6:00 am
· Mnemosyne Pharmaceuticals Inc., of Providence, received a $5,166,000 early stage investment from existing investors Atlas Venture Advisors Inc. and Clol Biotechnology Industries, Ltd. [read post]
